Trisenox (Arsenic trioxide) for Leukemia | MyLeukemiaTeam

Connect with others who understand.

sign up Log in
About MyLeukemiaTeam
Powered By

Trisenox is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating acute promyelocytic leukemia (APL) unresponsive to other forms of chemotherapy. Trisenox is reserved for APL characterized by a specific genetic transformation, the t(15;17) translocation. Trisenox is also referred to by its drug name, arsenic trioxide.

Trisenox is an anticancer drug, also called an antineoplastic or cytotoxic drug. Trisenox is believed to work by inducing cancer cell death.

How do I take it?
Trisenox is administered as an intravenous infusion.

Side effects
Common side effects of Trisenox include elevated white blood cell counts, headaches, fatigue, dizziness, cough, rash, itching, trouble breathing, high blood glucose, nausea, vomiting, diarrhea, abdominal pain, and edema (swelling).

Serious side effects of Trisenox include problems with electrical conduction in the heart, fetal harm in pregnant women, and increased risk for other types of cancer, even years after treatment has stopped. Trisenox can also cause differentiation syndrome, a life-threatening condition that causes trouble breathing and hypotension (low blood pressure).

For more details about this treatment, visit:

Arsenic trioxide — Chemocare

Treatment of Acute Promyelocytic Leukemia — Leukemia & Lymphoma Society

Trisenox — RxList

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in